Crispr Therapeutics shares owned by Foster Dykema Cabot & Partners
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Foster Dykema Cabot & Partners
from 13F filings
Historical chart of Foster Dykema Cabot & Partners investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Foster Dykema Cabot & Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Foster Dykema Cabot & Partners
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $682 | 10 | 68.20 |
More positions owned by Foster Dykema Cabot & Partners
View all positions for Foster Dykema Cabot & Partners